Please use this identifier to cite or link to this item:
Title: Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo
Authors: Kah, J.C.Y. 
Olivo, M. 
Chow, T.H.
Song, K.S.
Koh, K.Z.Y.
Mhaisalkar, S.
Sheppard, C.J.R. 
Keywords: Contrast agent
Contrast enhancement
Gold nanoshells
Mouse tumor
Optical coherence tomography
Tumor localization
Issue Date: 2009
Citation: Kah, J.C.Y., Olivo, M., Chow, T.H., Song, K.S., Koh, K.Z.Y., Mhaisalkar, S., Sheppard, C.J.R. (2009). Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo. Journal of Biomedical Optics 14 (5) : -. ScholarBank@NUS Repository.
Abstract: The control of image contrast is essential toward optimizing a contrast enhancement procedure in optical coherence tomography (OCT). In this study, the in vivo control of optical contrast in a mouse tumor model with gold nanoshells as a contrast agent is examined. Gold nanoshells are administered into mice, with the injected dosage and particle surface parameters varied and its concentration in the tumor under each condition is determined using a noninvasive theoretical OCT modeling technique. The results show that too high a concentration of gold nanoshells in the tumor only enhances the OCT signal near the tissue surface, while significantly attenuating the signal deeper into the tissue. With an appropriate dosage, IV delivery of gold nanoshells allows a moderate concentration of 6.2 × 10 9 particles/ml in tumor to achieve a good OCT signal enhancement with minimal signal attenuation with depth. An increase in the IV dosage of gold nanoshells reveals a corresponding nonlinear increase in their tumor concentration, as well as a nonlinear reduction in the fractional concentration of injected gold nanoshells. Furthermore, this fractional concentration is improved with the use of antiepodermal growth factor receptor (EGFR) surface functionalization, which also reduces the time required for tumor delivery from 6 to 2 h. © 2009 Society of Photo-Optical Instrumentation Engineers.
Source Title: Journal of Biomedical Optics
ISSN: 10833668
DOI: 10.1117/1.3233946
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jun 14, 2021


checked on Jun 14, 2021

Page view(s)

checked on Jun 8, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.